Drug Profile
Testosterone glucoside
Alternative Names: TOSTREXLatest Information Update: 06 Aug 2015
Price :
$50
*
At a glance
- Originator ProStrakan
- Class Anabolic steroids; Androstenols; Drug conjugates; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypogonadism
Most Recent Events
- 24 Jul 2015 Discontinued - Phase-II for Hypogonadism in World (PO)
- 21 Apr 2011 ProStrakan has been acquired by Kyowa Hakko Kirin
- 31 May 2007 Testosterone glucoside is still in phase I trials for Hypogonadism in Scotland